Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges
Author:
Affiliation:
1. University of Lahore, Pakistan
2. University of Central Punjab, Pakistan
3. University of Gujrat, Pakistan
Publisher
FapUNIFESP (SciELO)
Subject
Genetics,Molecular Biology
Link
http://www.scielo.br/pdf/gmb/v43n1/1415-4757-GMB-43-1-e20180160.pdf
Reference212 articles.
1. Signal transducer and activator of transcription-3, inflammation, and cancer;Aggarwal BB;Ann N Y Acad Sci,2009
2. Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1;Ahn KS;Cancer Res,2008
3. Ultraviolet B exposure activates Stat3 signaling via phosphorylation at tyrosine 705 in skin of SKH1 hairless mouse: A target for the management of skin cancer?;Ahsan H;Biochem Biophys Res Commun,2005
4. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway;Akira S;Cell,1994
5. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma;Aoki Y;Blood,2003
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Therapeutic potential of morin: Special focus on cognitive dysfunction, diabetes mellitus and cancer;Pharmacological Research - Modern Chinese Medicine;2023-12
2. Breast cancer and its therapeutic targets: A comprehensive review;Chemical Biology & Drug Design;2023-11-02
3. Target protein degradation by protacs: A budding cancer treatment strategy;Pharmacology & Therapeutics;2023-10
4. Ganoderenic acid D-loaded functionalized graphene oxide-based carrier for active targeting therapy of cervical carcinoma;Biomedicine & Pharmacotherapy;2023-08
5. Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma;Biomedicine & Pharmacotherapy;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3